Laminin 332 Expression in Breast Carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwon, Soon-Young | - |
dc.contributor.author | Chae, Seoung W. | - |
dc.contributor.author | Wilczynski, Sharon P. | - |
dc.contributor.author | Arain, Ahmad | - |
dc.contributor.author | Carpenter, Philip M. | - |
dc.date.accessioned | 2021-09-06T08:36:34Z | - |
dc.date.available | 2021-09-06T08:36:34Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2012-03 | - |
dc.identifier.issn | 1541-2016 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/105437 | - |
dc.description.abstract | Laminin 332 (LN332) is a basally expressed extracellular matrix protein that enhances the migration and invasion of breast carcinoma cells. The goal of this study was to examine LN332 expression breast carcinoma. Triple negative breast carcinomas lack estrogen receptor (ER), progesterone receptor (PR) expression and HER2 positivity. Immunohistochemistry for ER, PR, HER2, and dual silver in situ hybridization for the HER2 gene were used to define the phenotype of 243 breast cancers in biopsies or arrays. Immunohistochemistry for LN332 revealed that 70% of triple negative carcinomas stained for LN332. Cytokeratins 5/6 (CK5/6), epidermal growth factor receptor and p63 alone stained fewer triple negative breast carcinomas each, but the combination of LN332 and CK5/6 or epidermal growth factor receptor identified 92% of triple negative breast carcinoma. Of the 163 non-triple negative cases, LN332 was expressed in only 15%. The identification of LN332 in triple negative breast carcinomas is consistent with gene profiling studies showing its expression among breast carcinomas with a basal phenotype. The observation that a proinvasive protein such as LN332 is expressed in breast cancer suggests another mechanism by which the triple negative phenotype could be aggressive. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.subject | BASAL-LIKE PHENOTYPE | - |
dc.subject | IN-SITU HYBRIDIZATION | - |
dc.subject | EPITHELIAL-CELLS | - |
dc.subject | HER2 GENE | - |
dc.subject | CANCER | - |
dc.subject | MIGRATION | - |
dc.subject | SURVIVAL | - |
dc.subject | INVASION | - |
dc.subject | RECEPTOR | - |
dc.subject | ADHESION | - |
dc.title | Laminin 332 Expression in Breast Carcinoma | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kwon, Soon-Young | - |
dc.identifier.doi | 10.1097/PAI.0b013e3182329e8f | - |
dc.identifier.scopusid | 2-s2.0-84857911208 | - |
dc.identifier.wosid | 000300644600009 | - |
dc.identifier.bibliographicCitation | APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, v.20, no.2, pp.159 - 164 | - |
dc.relation.isPartOf | APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | - |
dc.citation.title | APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | - |
dc.citation.volume | 20 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 159 | - |
dc.citation.endPage | 164 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Anatomy & Morphology | - |
dc.relation.journalResearchArea | Medical Laboratory Technology | - |
dc.relation.journalResearchArea | Pathology | - |
dc.relation.journalWebOfScienceCategory | Anatomy & Morphology | - |
dc.relation.journalWebOfScienceCategory | Medical Laboratory Technology | - |
dc.relation.journalWebOfScienceCategory | Pathology | - |
dc.subject.keywordPlus | BASAL-LIKE PHENOTYPE | - |
dc.subject.keywordPlus | IN-SITU HYBRIDIZATION | - |
dc.subject.keywordPlus | EPITHELIAL-CELLS | - |
dc.subject.keywordPlus | HER2 GENE | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | MIGRATION | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | INVASION | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordPlus | ADHESION | - |
dc.subject.keywordAuthor | laminin 332 | - |
dc.subject.keywordAuthor | breast carcinoma | - |
dc.subject.keywordAuthor | basal-like phenotype | - |
dc.subject.keywordAuthor | triple negative | - |
dc.subject.keywordAuthor | immunohistochemistry | - |
dc.subject.keywordAuthor | HER2 dual in situ hybridization | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.